Samuel N. Hazen, CEO at HCA Healthcare, Inc. (HCA), sold 466,290 shares at $136.63 ($63.3M) on 2020-11-03, disclosed to the SEC on 2020-11-05.
Seasonal sale ($63.3M) by CEO — this insider has traded HCA in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.02 | 44,099 | $6.0M | 9.4% |
| 2 | $135.02 | 44,099 | $6.0M | 9.4% |
| 3 | $135.90 | 72,776 | $9.9M | 15.6% |
| 4 | $135.90 | 72,776 | $9.9M | 15.6% |
| 5 | $136.09 | 227,540 | $31.0M | 48.9% |
| 6 | $136.63 | 5,000 |
| $683K |
| 1.1% |
| Total | $135.83 avg | 466,290 | $63.3M | 100% |
| Filing → |
| HCA | SELL | 2018-02-02 | $5.6M | — | Filing → |
| HCA | SELL | 2015-04-17 | $14.4M | — | Filing → |
| HCA | SELL | 2014-12-29 | $13.5M | — | Filing → |